Media: AstraZeneca India recasts biopharma unit - ET
30/12/2024 03:05
- Source link: (https://shorturl.at/CVnNi)
- Note: Reuters has not verified this story and does not
vouch for its accuracy
(Bengaluru newsroom)
((ReutersIndia.snapping@thomsonreuters.com; +91 80 6749 1310;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication